Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $980.40, with a market capitalization of 926.87B. The stock trades at a price-to-earnings (P/E) ratio of 42.84 and offers a dividend yield of 63.4%.
As of 2026-03-06, Eli Lilly(LLY) stock has fluctuated between $965.60 and $1,009.00. The current price stands at $980.40, placing the stock +1.5% above today's low and -2.8% off the high.
Eli Lilly(LLY) shares are trading with a volume of 3.77M, against a daily average of 3.2M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The Phase 1b study “A Phase 1b Study of Abemaciclib Plus Darolutamide in Men W...
U.S. pharmaceutical giant Eli Lilly (LLY) has launched a new program designed to help more employers cover the cost of weight-loss medications. Currently, a la...
(RTTNews) - Eli Lilly and Company (LLY) on Thursday announced the launch of its Employer Connect platform, aimed at expanding access to obesity management treat...
Analyst ratings
79%
of 34 ratingsMore LLY News
Eli Lilly (LLY) announced the launch of its Employer Connect platform. Lilly’s platform expands choice, empowering employers to coordinate with independent prog...
Eli Lilly and Company (NYSE:LLY) rolled out its new Employer Connect platform on Wednesday, targeting the roughly half of commercially insured American employee...
Eli Lilly (NYSE:LLY) has entered a $1 billion AI-focused drug discovery partnership with Nvidia, aimed at using advanced computing to support pharmaceutical R&D...
Forget AI. This Biotech Stock’s Taking Off Right Now Quick Read Nvidia (NVDA) and Eli Lilly (LLY, down 7% YTD, forward P/E under 30x) in $1B partnership. Eli...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study titled “A Study to Evaluate the Effect of Fasting Duration and Tempo...
Ventyx Biosciences ( (VTYX) ) has issued an update. On January 7, 2026, Ventyx Biosciences, Inc. entered into a Merger Agreement with Eli Lilly and Company and...
Eli Lilly's (LLY 1.09%) big problem is its success in the GLP-1 drug space. Its Mounjaro (for diabetes) and Zepbound (for weight loss) drugs grew sales by 99% a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.